Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1011610

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that cystic fibrosis sufferers have access to Orkambi.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	194005
answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England are in dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2018 16:56:46 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

1011611

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will introduce a new 5-year survival target of 28 per cent by 2029 for (a) lung, (b) liver, (c) brain, (d) oesophageal, (e) pancreatic and (f) stomach cancer.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	194006
answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The Prime Minister announced ambitions for the National Health Service Long Term Plan that will see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these ambitions, we will need to make signification progress on survival across all cancers, including lung, liver, brain, oesophageal, pancreatic and stomach cancers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2018 17:24:18 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

988628

registered interest
date	16/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce geographical variation in (a) funding and (b) performance between and within Cancer Alliances.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	180311
answer	answer is ministerial correction date of answer 24/10/2018 answer text <p>In 2018/19, the National Cancer Programme established the National Support Fund for Cancer Alliances. The purpose of the National Support Fund is to address geographical variation in the transformation funding bids submitted by Cancer Alliances in 2017/18. The Fund is being used by Cancer Alliances to:</p><p>- improve, and sustain, performance against the 62-day cancer waiting-time standard; and</p><p>- underpin delivery of the relevant 2018/19 Planning Guidance priorities in a consistent way across the country.</p><p> </p><p>Alongside this, NHS England is providing an additional £10 million this financial year to improve and reduce variation in operational performance. This work will focus on:</p><p>- a nationwide initiative (particularly focused on urology) to grow capacity and support improvement activity across the county; and</p><p>- engaging with especially challenged areas to diagnose the root causes of their poor performance and to implement actions enabling the better management of additional patient demand.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/10/2018 12:34:48 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

982463

registered interest
date	08/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the next Pharmaceutical Price Regulation Scheme considers combination treatments for cancer to be cost-effective.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	175794
answer	answer is ministerial correction date of answer 16/10/2018 answer text <p>The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective, innovative cancer treatments and technologies at a price the National Health Service can afford. Discussions on a branded medicines voluntary agreement for 2019 onwards are ongoing and are constructive.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 175795 question first answered 16/10/2018 11:01:56 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

982464

registered interest
date	08/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the heads of agreement for the next Pharmaceutical Price Regulation Scheme will be published.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	175795
answer	answer is ministerial correction date of answer 16/10/2018 answer text <p>The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective, innovative cancer treatments and technologies at a price the National Health Service can afford. Discussions on a branded medicines voluntary agreement for 2019 onwards are ongoing and are constructive.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 175794 question first answered 16/10/2018 11:01:56 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

923263

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Oral Statement of 2 May 2018 on Breast Cancer Screening, Official Report, column 361, whether there is a record of the number of women who came forward to say they had not received an invitation to breast screening before May 2018.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	153162
answer	answer is ministerial correction date of answer 21/06/2018 answer text <p>There is no record held of the total number of women coming forward who have not received an invitation to breast screening before May 2018.</p><p> </p><p>Public Health England contacted 195,565 women registered with a general practitioner in England in May 2018. In addition, all the affected women known to have moved to Scotland, Wales or Northern Ireland were also written to by 1 June.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/06/2018 16:08:25 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

914714

registered interest
date	01/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Surveys
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the total cost has been of GP patient surveys issued over the period of 2013 to 2017.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	148590
answer	answer is ministerial correction date of answer 11/06/2018 answer text <p>NHS England inherited responsibility for the GP Patient Survey from the Department from 1 April 2013. During the period April 2013 to 2017 over 9.5 million patients were invited to take part in the survey at a cost of approximately £14.9 million.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/06/2018 14:45:41 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

903914

registered interest
date	14/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that all women (a) aged up to 72, and (b) who missed their final screening appointment will be able to access mammogram services within six months.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	143620
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>Any extra capacity being provided in response to this incident is being delivered in addition to existing capacity. The screening service for women aged 50-70 will continue to be delivered in the usual way.</p><p> </p><p>All women affected who wish to have a breast screen will receive an appointment to take place before the end of October 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/05/2018 11:06:22 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

885220

registered interest
date	17/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the Government's commissioned analysis by Ernst and Young of the effect of the UK leaving the EU on the medicines supply chain.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	136085
answer	answer is ministerial correction date of answer 25/04/2018 answer text <p>Due to the large volume of commercial and sensitive information that has been shared by the pharmaceutical industry throughout this work, the Department will be unable to publish the final report. However, we will consider publication of an executive summary of the work.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/04/2018 10:58:31 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

882485

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to add the maternal six week postnatal check to the General Medical Contract as recommended by the National Childbirth Trust.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	135547
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>Currently, the Department has no plans to add the maternal six week postnatal check to the General Medical Services Contract as recommended by the National Childbirth Trust.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guidance, Postnatal care up to 8 weeks after birth states “At the end of the postnatal period, the coordinating healthcare professional should ensure that the woman’s physical, emotional and social wellbeing is reviewed.” NHS England expects commissioners and providers of maternity care to pay due regard to the NICE guidelines.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 16:08:35 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake